Quick Connect Send a message
Dr. Reddy’s API team participated in DCAT 2026, engaging with global pharmaceutical customers and partners at one of the industry’s most important forums for business development and strategic collaboration.
During the event, the team held discussions around APIs, complex chemistries, supply reliability, and long‑term partnerships, reflecting the evolving expectations of global pharma companies. DCAT 2026 provided an opportunity to strengthen existing relationships and explore new opportunities across regulated and emerging markets. Participation at DCAT 2026 reaffirmed Dr. Reddy’s commitment to being a reliable, quality‑driven API partner, supporting customers with scalable and compliant solutions across the pharmaceutical value chain.
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.
+91 4049002253